iCell Cardiomyocytes

Grant Program

Press Releases

In the News

Events

Published Research

Webinars & Podcasts

Media Library

Subscribe to CDI News Updates

MEDIA CONTACT:
Joleen Rau
Senior Director
Marketing & Communications
Cellular Dynamics International, Inc.
(608) 310-5142
Contact Media Relations

For technical support or sales information:
+1 (608) 310-5100
US Toll-free: (877) 310-6688
Ext 3, Sales
Ext 5, Technical Support

CDI on TwitterCDI on YouTubeCDI on LinkedIn

Innovative Research Grant Program

APPLICATIONS ARE NO LONGER BEING ACCEPTED FOR THE INITIAL GRANT (JUL 25 - SEP 12, 2011).

iCell Cardiomyocytes
iCell Cardiomyocytes and Media

CDI's Innovative Research Grant Program awards high-quality human induced pluripotent stem cell-derived cells for progressive basic, applied, and industrial research.

The initial grant provides iCell® Cardiomyocytes for proposed research projects that will advance the understanding of cardiovascular cellular biology and/or the utilization of human cardiomyocytes in industrial applications. Maximum consideration will be placed on those projects that take advantage of the human origin of the cardiomyocytes, seek to address problems of significant scientific and/or industrial merit, represent novel investigations, have widespread applicability, and provide the basis for further studies.

Award winner(s) will be expected to participate in a limited number of marketing programs highlighting their research performed under the grant award.

Important Dates

  • Application start date: Jul 25, 2011
  • Application deadline: Sep 12, 2011
  • Winners notified: Nov 2, 2011

How to Apply

Read the program's Official Rules and apply for the grant using the online form.

If you have any questions about this program, email grant@cellulardynamics.com.

Apply

Applications are no longer being accepted for the initial grant (Jul 25 - Sep 12, 2011).

Official Rules

Please read these Rules before submitting a Research Grant Application. By submitting an Application you agree to be bound by these Rules and that you satisfy all eligibility requirements.

1. HOW TO ENTER:

  • Research Grant Applications will be accepted by CDI from 12:01 a.m. on July 25, 2011 CDT until 12:00 a.m. CDT September 12, 2011. You must submit your Research Grant Application through the CDI Grant webpage at http://www.cellulardynamics.com/news/grant_program/grant_program.php (collectively, the Application).

2. GENERAL RULES APPLICABLE TO CDI’S INNOVATIVE RESEARCH GRANT PROGRAM (the Program):

  • In the event of a dispute regarding any Application, that Application will be deemed made by the authorized holder of the primary email address associated with the Application.
  • By submitting an Application, Applicants agree to be bound by these Rules.
  • CDI’s failure to enforce any term or provision of these Rules shall not constitute a waiver of the term or provision or any other term.
  • CDI reserves the right, at its sole discretion, to cancel, terminate, modify or suspend this Program.
  • These Rules are subject to change without notice for any reason.
  • All Applications, and all parts of the Application, become the property of CDI and will not be returned to the Applicant.  Applicant agrees that the Application shall not include any confidential information or trade secret information of the Applicant or his/her employer and that the Application itself shall not constitute confidential information or trade secret information of the Applicant or his/her employer. CDI will have no liability or obligation to keep confidential or for non-use of any information submitted in an Application.
  • Each winning Applicant agrees to report the work product, data or results from the research proposal described in the Application to CDI.  If a winning Applicant wants to publicly present or publish the work product, data and results of the research proposal described in the Application it will need CDI’s approval prior to such publication or presentation.  Also, if requested, each winning Applicant will publish or present on the work product, data or results from the research proposal described in the Application.  Additionally, CDI may publicize for its own purposes the research proposal in the winning Applications and the work product, data and results if made public by the Applicant pursuant to these Rules.
  • The Program is void where prohibited.

3. RESEARCH PROPOSAL WINNERS:

  • CDI will evaluate each Application based on CDI’s determination of the best ideas for the development of new applications for basic, applied, and industrial research using iCell® Cardiomyocytes. The winners will be selected based on the scientific merit of the Application and the resources and expertise that the Applicant can bring to the submitted projects.  The criteria to judge each Application is subjective and shall be at CDI’s sole discretion.
  • Judging to determine the winners will be done by a panel appointed by CDI (the Grant Committee).
  • The decision of the Grant Committee will be final and cannot be appealed.

4. NOTIFICATION:

  • Winners will be notified no later than November 2, 2011.
  • No information regarding judging will be disclosed.

5. AWARD:

  • Each winning Application will receive an amount of iCell® Cardiomyocytes (the Award) that are anticipated to be sufficient to complete the proposed research.
  • No financial or other compensation will be awarded.
  • The Award is not transferable; no substitutions or cash equivalents will be provided.
  • Taxes, if any, related to the Award are the responsibility of the winners.
  • To accept an Award, Applicants (and his or her employer) of winning Applications must agree to the Terms and Conditions of Sale for iCell® Cardiomyocytes and will be required to sign and return a declaration of eligibility, a release of liability and an assignment of rights in accordance with these Rules.
  • All expenses and costs associated with the Application are the sole responsibility of the winner.
  • Research activities proposed within the Application must be completed within six (6) months of receipt of Award.
  • The Award must be used for the research proposal described in the Application.
  • The Award will be shipped to the winner within 30 days of Applicant’s return of the executed terms and conditions and declaration described above.

6. ELIGIBILITY:

  • Each Applicant must be an individual who is at least 18 years old.
  • Applications that propose research on IVD-regulated products (for In Vitro Diagnostic Use), use in clinical trials, or any use in humans are excluded from the Program and will disqualify any Application.
  • Employees of CDI are not eligible to participate in the Program.
  • By submitting an Application, each Applicant consents to the use and publication by CDI of an Applicant's (and his or her employer’s) name, biographical information, likeness, company/employer information, and the research proposal described in the Application without further compensation, except where prohibited by law and as otherwise provided herein.
  • By entering, Applicant gives permission to CDI to contact Applicant about CDI’s products and services, whether or not Applicant’s Application is chosen as a winner.

7. INTELLECTUAL PROPERTY:

  • Ownership of the pre-existing, underlying intellectual property of the Applicant remains the property of the Applicant subject to CDI's rights described below.
  • By participating in the Program, each winning Applicant grants to CDI a non-exclusive, worldwide, fully paid, royalty-free, perpetual, transferable license to reprint, display, reproduce, publish, use and exhibit (including the right to modify and make derivative works of) the Application and materials, and information submitted on and in connection with the Application or use or receipt of the Award, as well as materials and information provided to CDI for the purposes of running the Program.
  • Each participating Applicant hereby warrants that any Application and other materials and information provided by Applicant are original to Applicant and do not violate or infringe upon the intellectual property or other rights of any other person or entity.   If the Application or information or materials provided by Applicant contain any material or elements that are not owned by Applicant and/or which are subject to the rights of third parties, Applicant agrees to disclose such information in the Application and represents that he or she has obtained, prior to submission of the Application and information or materials, any and all releases and consents necessary to permit the use and exploitation of the Application, information and materials by CDI in the manner set forth in these Rules without additional compensation.  Any and all such permission, licenses, clearances, releases, waivers and approvals may be requested by CDI.

8.  RELEASE/LIMITATIONS OF LIABILITY:

  • EACH APPLICANT (AND HIS OR HER EMPLOYER) HEREBY HOLDS CDI AND ITS SHAREHOLDERS, DIRECTORS, OFFICERS, EMPLOYEES, AND AGENTS HARMLESS FROM AND AGAINST ALL CLAIMS, LOSSES, DEMANDS, DAMAGES OR LIABILITIES OF ANY KIND OR NATURE ARISING FROM OR RELATING TO APPLICANT’S SUBMISSION OF AN  APPLICATION; CDI’S USE OF THAT APPLICATION AS PERMITTED BY THESE RULES; AND IF THE APPLICANT SUBMITS A WINNING APPLICATION, THE RECEIPT OR USE BY APPLICANT OF THE AWARD.
  • CDI AND ITS SHAREHOLDERS, DIRECTORS, OFFICERS, EMPLOYEES, AND AGENTS ARE NOT RESPONSIBLE FOR LOST, LATE, DAMAGED, MISDIRECTED, ILLEGIBLE, INCOMPLETE OR APPLICATIONS; OR FOR ANY COMPUTER, ONLINE, TELEPHONE OR TECHNICAL MALFUNCTIONS, DELAYS OR HUMAN ERRORS THAT OCCUR IN THE PROCESSING, TRANSMISSION OR RECEIPT OF APPLICATIONS OR FOR INACCURATE TRANSCRIPTION OF APPLICATION INFORMATION; OR FOR ENTRIES THAT ARE STOLEN, MISDIRECTED, GARBLED, LOST OR DELAYED BY COMPUTER TRANSMISSIONS; OR IF FOR ANY REASON THE CONTEST IS NOT CAPABLE OF BEING CONDUCTED AS PLANNED, INCLUDING BUT NOT LIMITED TO INFECTION BY COMPUTER VIRUSES, BUGS, TAMPERING, UNAUTHORIZED INTERVENTION, FRAUD, TECHNICAL FAILURES OR OTHER CAUSES BEYOND THE CONTROL OF CDI.
  • CDI RESERVES THE RIGHT AT ITS SOLE DISCRETION TO CANCEL, TERMINATE, MODIFY OR SUSPEND THE PROGRAM.  CDI RESERVES THE RIGHT NOT TO CHOOSE ANY WINNING APPLICATIONS OR TO CHOOSE MULTIPLE WINNING APPLICATIONS.
  • EACH WINNING APPLICANT ASSUMES ALL LIABILITY AND RISK FOR ITS USE OF THE AWARD PURSUANT TO THE PROGRAM AND FOR THE PERFORMANCE OF THE RESEARCH DESCRIBED IN THE APPLICATION.

9. CHOICE OF LAW; VENUE:

  • By submitting an Application, each Applicant agrees that all issues and questions concerning the construction, validity, interpretation or enforceability of these Rules, the Applicant’s rights and obligations under the Program, and CDI’s rights and obligations under the Program shall be governed by and construed in accordance with Wisconsin law. By submitting an Application, each Applicant consents to the jurisdiction of the federal and state courts of Wisconsin, with venue in Dane County.

10. WINNING APPLICATIONS:

  • A list of winning Application(s) may be posted on the CDI website for a period of time after the winning Application(s) has been selected.

Winners

Due to overwhelming response in submissions, we have extended our review time one week. Award winners will be notified Nov 2, 2011. Return to this webpage to learn about the recipients and their research.